Fig. 12From: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitroEffects of SZL-containing serum with PI3K and/or GSK3β inhibitor. Statistical analysis of protein expressions of p-Akt (A1), p-GSK3β (A2), GLUT1 (A3), GLUT3 (A4) with PI3K inhibitor. Statistical analysis of protein expressions of p-GSK3β (B1), GLUT1 (B2), GLUT3 (B3) with GSK3β inhibitor. Statistical analysis of protein expressions of GLUT1 (C1), GLUT3 (C2) with PI3K and GSK3β inhibitor. CG: control group. All data are presented as means ± SEM (n = 6). *P < 0.05, **P < 0.01 versus Control group, △P < 0.05, △△P < 0.01 versus Model group; ▼P < 0.05, ▼▼P < 0.01 versus SZL-containing serum group; One-way ANOVA was used to calculate the p-valuesBack to article page